China's NMPA has approved a rare-disease therapy for commercial sales to treat narcolepsy type 1 in individuals aged 16 and older. The unnamed drug previously received fast-track status in the US and orphan-drug designation in Japan and the EU, indicating international recognition for its importance.
A former University of Hawaii football recruiter alleges she faced discrimination after disclosing a narcolepsy diagnosis, claiming male colleagues slept during work without consequence while she was scrutinized. Ella Devenny's lawsuit details claims of disability and gender discrimination, retaliation, and wrongful termination.
Ella Devenny, former director of recruiting for the University of Hawai'i's football program, filed a federal civil rights lawsuit alleging discrimination based on her narcolepsy diagnosis and gender. She claims she faced increased scrutiny and was ultimately fired after disclosing her condition, while male colleagues sleeping on the job faced no comparable consequences.
